The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses
Abstract
1. Introduction
2. Methods
Statistical Analysis
3. Results
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Virani, S.S.; Alonso, A.; Aparicio, H.J.; Benjamin, E.J.; Bittencourt, M.S.; Callaway, C.W.; Carson, A.P.; Chamberlain, A.M.; Cheng, S.; Delling, F.N.; et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation 2021, 143, e254–e743. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Falk, E.; Shah, P.K.; Fuster, V. Coronary plaque disruption. Circulation 1995, 92, 657. [Google Scholar] [CrossRef] [Scilit]
- Neumann, F.J.; Sousa-Uva, M.; Ahlsson, A.; Alfonso, F.; Banning, A.P.; Benedetto, U.; Byrne, R.A.; Collet, J.P.; Falk, V.; Head, S.J.; et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019, 40, 87–165. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Caldwell, M.; Martinez, L.; Foster, J.G.; Sherling, D.; Hennekens, C.H. Prospects for the Primary Prevention of Myocardial Infarction and Stroke. J. Cardiovasc. Pharmacol. Ther. 2019, 24, 207–214. [Google Scholar] [CrossRef] [Scilit]
- Faria, D.; Mejia-Renteria, H.; Lee, J.M.; Lee, S.H.; Travieso, A.; Jung, J.H.; Doh, J.H.; Nam, C.W.; Shin, E.S.; Hoshino, M.; et al. Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis. Catheter. Cardiovasc. Interv. 2022, 100, 1195–1205. [Google Scholar] [CrossRef] [Scilit]
- Chareonthaitawee, P.; Kaufmann, P.A.; Rimoldi, O.; Camici, P.G. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc. Res. 2001, 50, 151–161. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Uren, N.G.; Camici, P.G.; Melin, J.A.; Bol, A.; de Bruyne, B.; Radvan, J.; Olivotto, I.; Rosen, S.D.; Impallomeni, M.; Wijns, W. Effect of aging on myocardial perfusion reserve. J. Nucl. Med. 1995, 36, 2032–2036. [Google Scholar]
- Toth, G.; Hamilos, M.; Pyxaras, S.; Mangiacapra, F.; Nelis, O.; De Vroey, F.; Di Serafino, L.; Muller, O.; Van Mieghem, C.; Wyffels, E.; et al. Evolving concepts of angiogram: Fractional flow reserve discordances in 4000 coronary stenoses. Eur. Heart J. 2014, 35, 2831–2838. [Google Scholar] [CrossRef] [Scilit]
- Svanerud, J.; Ahn, J.M.; Jeremias, A.; van‘t Veer, M.; Gore, A.; Maehara, A.; Crowley, A.; Pijls NH, J.; De Bruyne, B.; Johnson, N.P.; et al. Validation of a novel non-hyperemic index of coronary artery stenosis severity: The Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention. 2018, 14, 806–814. [Google Scholar] [CrossRef] [Scilit]
- Faria, D.C.; Lee, J.M.; van der Hoef, T.; Mejía-Rentería, H.; Echavarría-Pinto, M.; Baptista, S.B.; Cerrato, E.; Garcia-Garcia, H.M.; Davies, J.; Onuma, Y.; et al. Age and functional relevance of coronary stenosis: A post hoc analysis of the ADVISE II trial. EuroIntervention 2021, 17, 757–764. [Google Scholar] [CrossRef] [Scilit]
- Zuhdi, A.S.; Mariapun, J.; Mohd Hairi, N.N.; Wan Ahmad, W.A.; Abidin, I.Z.; Undok, A.W.; Ismail, M.D.; Sim, K.H. Young coronary artery disease in patients undergoing percutaneous coronary intervention. Ann. Saudi Med. 2013, 33, 572–578. [Google Scholar] [CrossRef] [Scilit]
- Zasada, W.; Bobrowska, B.; Plens, K.; Dziewierz, A.; Siudak, Z.; Surdacki, A.; Dudek, D.; Bartuś, S. Acute myocardial infarction in young patients. Kardiol. Pol. 2021, 79, 1093–1098. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Miyazaki, T.; Ashikaga, T.; Ohigashi, H.; Komura, M.; Kobayashi, K.; Isobe, M. Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease. Int. Heart J. 2015, 56, 29–36. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Czernin, J.; Sun, K.; Brunken, R.; Böttcher, M.; Phelps, M.; Schelbert, H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995, 91, 2891–2897. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Morita, K.; Tsukamoto, T.; Naya, M.; Noriyasu, K.; Inubushi, M.; Shiga, T.; Katoh, C.; Kuge, Y.; Tsutsui, H.; Tamaki, N. Smoking cessation normalizes coronary endothelial vasomotor response assessed with 15O-water and PET in healthy young smokers. J. Nucl. Med. 2006, 47, 1914–1920. [Google Scholar]
- Naya, M.; Morita, K.; Yoshinaga, K.; Manabe, O.; Goto, D.; Hirata, K.; Katoh, C.; Tamaki, N.; Tsutsui, H. Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers. Eur. J. Nucl. Med. Mol. Imaging 2011, 38, 491–498. [Google Scholar] [CrossRef] [Scilit]
- Kim, H.S.; Tonino, P.A.; De Bruyne, B.; Yong, A.S.; Tremmel, J.A.; Pijls, N.H.; Fearon, W.F.; FAME Study Investigators. The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) substudy. JACC Cardiovasc. Interv. 2012, 5, 1037–1042. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kim, C.H.; Koo, B.K.; Lee, J.M.; Shin, E.S.; Park, J.; Choi, K.H.; Hwang, D.; Rhee, T.M.; Zhang, J.; Choi, Y.J.; et al. Influence of Sex on Relationship Between Total Anatomical and Physiologic Disease Burdens and Their Prognostic Implications in Patients with Coronary Artery Disease. J. Am. Heart Assoc. 2019, 8, e011002. [Google Scholar] [CrossRef] [Scilit]
- Shah, S.V.; Zimmermann, F.M.; Johnson, N.P.; Nishi, T.; Kobayashi, Y.; Witt, N.; Berry, C.; Jeremias, A.; Koo, B.K.; Esposito, G.; et al. Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST Substudy. JACC Cardiovasc. Interv. 2018, 11, 1454–1463. [Google Scholar] [CrossRef] [Scilit]
- Kim, C.H.; Koo, B.K.; Dehbi, H.M.; Lee, J.M.; Doh, J.H.; Nam, C.W.; Shin, E.S.; Cook, C.M.; Al-Lamee, R.; Petraco, R.; et al. Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy. JACC Cardiovasc. Interv. 2019, 12, 2035–2046. [Google Scholar] [CrossRef] [Scilit]
- Kobayashi, Y.; Fearon, W.F.; Honda, Y.; Tanaka, S.; Pargaonkar, V.; Fitzgerald, P.J.; Lee, D.P.; Stefanick, M.; Yeung, A.C.; Tremmel, J.A. Effect of Sex Differences on Invasive Measures of Coronary Microvascular Dysfunction in Patients with Angina in the Absence of Obstructive Coronary Artery Disease. JACC Cardiovasc. Interv. 2015, 8, 1433–1441. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Reis, S.E.; Holubkov, R.; Conrad Smith, A.J.; Kelsey, S.F.; Sharaf, B.L.; Reichek, N.; Rogers, W.J.; Merz, C.N.; Sopko, G.; Pepine, C.J.; et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am. Heart J. 2001, 141, 735–741. [Google Scholar] [CrossRef] [Scilit]
- Kim, H.Y.; Lim, H.S.; Doh, J.H.; Nam, C.W.; Shin, E.S.; Koo, B.K.; Yoon, M.H.; Tahk, S.J.; Kang, D.K.; Song, Y.B.; et al. Physiological Severity of Coronary Artery Stenosis Depends on the Amount of Myocardial Mass Subtended by the Coronary Artery. JACC Cardiovasc. Interv. 2016, 9, 1548–1560. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sheifer, S.E.; Canos, M.R.; Weinfurt, K.P.; Arora, U.K.; Mendelsohn, F.O.; Gersh, B.J.; Weissman, N.J. Sex differences in coronary artery size assessed by intravascular ultrasound. Am. Heart J. 2000, 139, 649–653. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zasada, W.; Mikołajczyk, F.; Jędrychowska, M.; Malinowski, K.; Bobrowska, B.; Partyka, L.; Bartuś, S.; Dziewierz, A. Comparison of FFR, iFR, and QFR assessment in patients with severe aortic stenosis and coronary heart disease. Adv. Interv. Cardiol. 2022, 18, 118–121. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wieneke, H.; Haude, M.; Ge, J.; Altmann, C.; Kaiser, S.; Baumgart, D.; von Birgelen, C.; Welge, D.; Erbel, R. Corrected coronary flow velocity reserve: A new concept for assessing coronary perfusion. J. Am. Coll. Cardiol. 2000, 35, 1713–1720. [Google Scholar] [CrossRef] [Scilit]
- Ziubryte, G.; Jarusevicius, G. Fractional flow reserve, quantitative flow ratio, and instantaneous wave-free ratio: A comparison of the procedure-related dose of ionising radiation. Adv. Interv. Cardiol. 2021, 17, 33–38. [Google Scholar] [CrossRef] [Scilit] [PubMed]

| Group | p-Value | ||
|---|---|---|---|
| Younger (≤60 y.o.) 92 (24.1%) | Older (>60 y.o.) 289 (75.9%) | ||
| Gender, female, n (%) | 15 (16.3) | 77 (26.6) | 0.044 |
| Height, cm, median (Q1–Q3) | 172.0 (168.0–177.0) | 170.0 (165.0–176.0) | 0.030 |
| Weight, kg, median (Q1–Q3) | 88.0 (76.0–98.0) | 84.0 (73.0–92.0) | 0.027 |
| BMI, kg/m2, median (Q1–Q3) | 29.1 (26.2–32.3) | 28.4 (25.3–31.5) | 0.23 |
| Diabetes mellitus, n (%) | 27 (29.4) | 127 (43.9) | 0.013 |
| Arterial hypertension, n (%) | 73 (79.4) | 258 (89.6) | 0.011 |
| Atrial fibrillation, n (%) | 8 (8.7) | 67 (23.3) | 0.002 |
| Previous MI, n (%) | 42 (45.7) | 136 (47.1) | 0.81 |
| Previous PCI, n (%) | 40 (43.5) | 156 (54.0) | 0.08 |
| Previous CABG, n (%) | 1 (1.1) | 13 (4.51) | 0.20 |
| PAD, n (%) | 5 (5.4) | 48 (16.7) | 0.007 |
| Current smoker, n (%) | 55 (59.8) | 135 (46.7) | 0.029 |
| COPD, n (%) | 4 (4.4) | 23 (8.0) | 0.24 |
| Previous stroke/TIA, n (%) | 5 (5.4) | 30 (10.4) | 0.15 |
| Dyslipidemia, n (%) | 72 (78.3) | 221 (76.5) | 0.72 |
| GFR, mL/min/1.73 m2, mean (SD) | 81.8 (25.9) | 74.7 (25.9) | 0.025 |
| LVEF, %, median (Q1–Q3) | 50.0 (41.0–60.0) | 53.0 (40.0–60.0) | 0.75 |
| Radial access, n (%) | 78 (84.8) | 235 (81.3) | 0.45 |
| Group | p-Value | ||
|---|---|---|---|
| Younger (≤ 60 y.o.) 103 (24.7%) | Older (>60 y.o.) 314 (75.3%) | ||
| Vessel assessed | |||
| LAD | 64 (62.1%) | 185 (58.9%) | 0.56 |
| non-LAD | 39 (37.9%) | 129 (41.1%) | |
| All vessels | |||
| FFR ≤ 0.80, n (%) | 50 (48.5%) | 150 (47.8%) | 0.89 |
| FFR, median (Q1–Q3) | 0.81 (0.75–0.87) | 0.815 (0.76–0.88) | 0.52 |
| iFR/RFR ≤ 0.89, n (%) | 44 (42.7%) | 150 (47.8%) | 0.37 |
| iFR/RFR, median (Q1–Q3) | 0.90 (0.87–0.94) | 0.90 (0.85–0.94) | 0.50 |
| LAD | |||
| FFR ≤ 0.80, n (%) | 35 (54.7%) | 114 (61.6%) | 0.33 |
| FFR, median (Q1–Q3) | 0.80 (0.75–0.85) | 0.78 (0.73–0.84) | 0.43 |
| iFR/RFR ≤ 0.89, n (%) | 34 (53.1%) | 111 (60.0%) | 0.34 |
| iFR/RFR, median (Q1–Q3) | 0.89 (0.8625–0.92) | 0.88 (0.83–0.92) | 0.16 |
| Non-LAD | |||
| FFR ≤ 0.80, n (%) | 15 (38.5%) | 36 (27.9%) | 0.21 |
| FFR, median (Q1–Q3) | 0.83 (0.76–0.90) | 0.86 (0.80–0.91) | 0.16 |
| iFR/RFR ≤ 0.89, n (%) | 10 (25.6%) | 39 (30.2%) | 0.58 |
| iFR/RFR, median (Q1–Q3) | 0.93 (0.88–0.97) | 0.94 (0.88–0.97) | 0.89 |
| Concordance-general | |||
| concordant | 81 (78.6%) | 256 (81.5%) | 0.52 |
| discordant | 22 (21.4%) | 58 (18.5%) | |
| FFR−|iFR/RFR− | 45 (43.7%) | 135 (43.0%) | 0.60 |
| FFR−|iFR/RFR+ | 8 (7.8%) | 29 (9.2%) | |
| FFR+|iFR/RFR− | 14 (13.6%) | 29 (9.2%) | |
| FFR+|iFR/RFR+ | 36 (35.0%) | 121 (38.5%) | |
| Crude OR Younger Group (95% Confidence Interval) | p-Value | Crude OR Older Group (95% Confidence Interval) | p-Value | |
|---|---|---|---|---|
| Predictors of FFR+ | ||||
| Gender, male | 1.35 (0.50–3.76) | 0.54 | 2.45 (1.46–4.12) | 0.001 |
| DM, yes | 2.62 (1.13–6.05) | 0.015 | 1.44 (0.92–2.26) | 0.11 |
| PAD, yes | 5.78 (0.65–51.31) | 0.12 | 1.86 (1.05–3.30) | 0.034 |
| Smoking, yes | 3.49 (1.42–8.62) | 0.007 | 1.07 (0.69–1.67) | 0.75 |
| Age (continuous, per 1 year) | 0.97 (0.90–1.04) | 0.35 | 0.99 (0.96–1.03) | 0.73 |
| Predictors of iFR/RFR+ | ||||
| Gender, male | 1.35 (0.48–3.77) | 0.57 | 1.74 (1.05–2.88) | 0.032 |
| DM, yes | 0.66 (0.29–1.51) | 0.32 | 1.69 (1.08–2.65) | 0.023 |
| PAD, yes | 1.37 (0.26–7.11) | 0.71 | 2.41 (1.34–4.34) | 0.003 |
| DM on insulin, yes | 1.26 (0.28–5.65) | 0.76 | 2.25 (1.12–4.55) | 0.023 |
| Age (continuous, per 1 year) | 0.93 (0.87–1.00) | 0.056 | 1.03 (0.99–1.06) | 0.08 |
| Male Group (n = 311) | Female Group (n = 106) | p-Value | |
|---|---|---|---|
| All vessels-younger group | |||
| FFR ≤ 0.80, n (%) | 42 (50.0) | 8 (42.1) | 0.53 |
| FFR, median (Q1–Q3) | 0.805 (0.7525–0.86) | 0.86 (0.74–0.9) | 0.44 |
| iFR/RFR ≤ 0.89, n (%) | 37 (44.1) | 7 (36.8) | 0.57 |
| iFR/RFR, median (Q1–Q3) | 0.90 (0.87–0.94) | 0.93 (0.86–0.97) | 0.42 |
| All vessels-older group | |||
| FFR ≤ 0.80, n (%) | 122 (53.7) | 28 (32.2) | 0.001 |
| FFR, median (Q1–Q3) | 0.8 (0.75–0.86) | 0.85 (0.78–0.91) | <0.001 |
| iFR/RFR ≤ 0.89, n (%) | 117 (51.5) | 33 (37.9) | 0.031 |
| iFR/RFR, median (Q1–Q3) | 0.89 (0.84–0.94) | 0.92 (0.87–0.95) | 0.06 |
| Smoking Group (n = 223) | Non-Smoking Group (n = 194) | p-Value | |
|---|---|---|---|
| All vessels-younger group | |||
| FFR ≤ 0.80, n (%) | 41 (57.8) | 9 (28.1) | 0.005 |
| FFR, median (Q1–Q3) | 0.79 (0.75–0.86) | 0.845 (0.8–0.9) | 0.006 |
| iFR/RFR ≤ 0.89, n (%) | 34 (47.9) | 10 (31.3) | 0.11 |
| iFR/RFR, median (Q1–Q3) | 0.90 (0.86–0.94) | 0.915 (0.89–0.94) | 0.15 |
| All vessels-older group | |||
| FFR ≤ 0.80, n (%) | 74 (48.7) | 76 (46.9) | 0.75 |
| FFR, median (Q1–Q3) | 0.81 (0.76–0.87) | 0.83 (0.76–0.89) | 0.17 |
| iFR/RFR ≤ 0.89, n (%) | 76 (50.0) | 74 (45.7) | 0.44 |
| iFR/RFR, median (Q1–Q3) | 0.895 (0.84–0.94) | 0.90 (0.8575–0.94) | 0.76 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zasada, W.; Zdzierak, B.; Rakowski, T.; Bobrowska, B.; Krawczyk-Ożóg, A.; Surowiec, S.; Bartuś, S.; Surdacki, A.; Dziewierz, A. The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses. Medicina 2023, 59, 1863. https://doi.org/10.3390/medicina59101863
Zasada W, Zdzierak B, Rakowski T, Bobrowska B, Krawczyk-Ożóg A, Surowiec S, Bartuś S, Surdacki A, Dziewierz A. The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses. Medicina. 2023; 59(10):1863. https://doi.org/10.3390/medicina59101863
Chicago/Turabian StyleZasada, Wojciech, Barbara Zdzierak, Tomasz Rakowski, Beata Bobrowska, Agata Krawczyk-Ożóg, Sławomir Surowiec, Stanisław Bartuś, Andrzej Surdacki, and Artur Dziewierz. 2023. "The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses" Medicina 59, no. 10: 1863. https://doi.org/10.3390/medicina59101863
APA StyleZasada, W., Zdzierak, B., Rakowski, T., Bobrowska, B., Krawczyk-Ożóg, A., Surowiec, S., Bartuś, S., Surdacki, A., & Dziewierz, A. (2023). The Impact of Age on the Physiological Assessment of Borderline Coronary Stenoses. Medicina, 59(10), 1863. https://doi.org/10.3390/medicina59101863

